Anemia Drugs Market

Anemia Drugs Market contains market size and forecasts of Anemia Drugs in global, including the following market information:

• Global Anemia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Anemia Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Anemia Drugs companies in 2021 (%)

The global Anemia Drugs market was valued at 12170 million in 2021 and is projected to reach US$ 16340 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anemia Drugs include GlaxoSmithKline, Global Blood Therapeutics (GBT), Bluebird Bio, GlycoMimetics, Mast Therapeutics, Fibrogen, Akebia Therapeutics, Bayer AG and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anemia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anemia Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Anemia Drugs Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection

Global Anemia Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Anemia Drugs Market Segment Percentages, by Application, 2021 (%)

• Iron Deficiency Anemia
• Chronic Kidney Disease related Anemia
• Sickle Cell Anemia
• Aplastic Anemia

Global Anemia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Anemia Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Anemia Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Anemia Drugs revenues share in global market, 2021 (%)
• Key companies Anemia Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Anemia Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Global Blood Therapeutics (GBT)
• Bluebird Bio
• GlycoMimetics
• Mast Therapeutics
• Fibrogen
• Akebia Therapeutics
• Bayer AG
• Eli Lilly
• Regen Biopharma
• Acceleron Pharma
• Celgene Corporation
• Onconova Therapeutics
• Pieris Pharmaceuticals